Market Cap: $159.94B
Market Cap: $159.94B
Open
$24.16
Prev. Close
$28.47
High
$24.16
Low
$23.62
Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide.
Pfizer Inc. trades on the New York Stock Exchange under the ticker PFE, priced in USD.
Pfizer Inc. has a market capitalisation of $159.94B, based on its latest share price.
PFE trades at 38.91 times its trailing 12-month earnings.
Over the past 52 weeks PFE has traded between $23.62 and $31.44.
Yes. Pfizer Inc.'s dividend yields 5.84% at the current share price, paying out 226% of its earnings.
Profitable, with a net margin of 6.8% over the last 12 months.
Albert Bourla is the CEO of Pfizer Inc., which is headquartered in New York City.
Generated automatically from reported financial data. General information only, not financial advice.

Pfizer Inc. ( PFE ) is drawing attention as the latest developments come into focus. Pfizer Inc. (PFE) is entering a critical phase as it maneuvers through the looming threats of patent expirations th…

Pfizer Inc. ( PFE ) is currently navigating a pivotal transformation, emphasizing its oncology portfolio to counterbalance impending revenue losses from patent expirations. The pharmaceutical giant fa…

Pfizer Inc. ( PFE ) is navigating a pivotal transformation centered on expanding its oncology portfolio to counterbalance the looming threats of revenue decline from patent expirations. The company's…

In an ever-evolving pharmaceutical landscape, Pfizer Inc. ( PFE ) is strategically pivoting to mitigate the impending challenges posed by patent expirations of its key blockbuster products. As the com…